The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Insulin Raw Material Market Research Report 2025
Synopsis
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China. In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
The global Insulin Raw Material market was valued at US$ 1943 million in 2023 and is anticipated to reach US$ 2482.7 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
The Insulin Raw Material market is driven by the increasing prevalence of diabetes and the growing demand for insulin production to address the global healthcare burden. Insulin, a vital hormone for managing blood sugar levels, requires high-quality raw materials for its synthesis. The rise in diabetes cases, both type 1 and type 2, contributes to market growth as pharmaceutical companies seek reliable sources of raw materials to meet the escalating insulin demand. Moreover, advancements in biotechnology and genetic engineering align with improved insulin production methods and potential innovations in insulin analogs. However, the market also faces challenges, including the complexity of insulin production processes and the need to adhere to stringent regulatory standards for quality and safety. Additionally, addressing affordability concerns and potential supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on sustainable sourcing, research and development for efficient production methods, and addressing the challenges to meet the increasing demand for insulin while ensuring its accessibility to a diverse diabetic population worldwide.
This report aims to provide a comprehensive presentation of the global market for Insulin Raw Material, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Raw Material.
Report Scope
The Insulin Raw Material market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Raw Material market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Raw Material manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
Segment by Type
Regular Human Insulin
Insulin Analogue
Segment by Application
Fast-acting
Intermediate-acting
Long-acting
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Raw Material manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Raw Material in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China. In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
The global Insulin Raw Material market was valued at US$ 1943 million in 2023 and is anticipated to reach US$ 2482.7 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
The Insulin Raw Material market is driven by the increasing prevalence of diabetes and the growing demand for insulin production to address the global healthcare burden. Insulin, a vital hormone for managing blood sugar levels, requires high-quality raw materials for its synthesis. The rise in diabetes cases, both type 1 and type 2, contributes to market growth as pharmaceutical companies seek reliable sources of raw materials to meet the escalating insulin demand. Moreover, advancements in biotechnology and genetic engineering align with improved insulin production methods and potential innovations in insulin analogs. However, the market also faces challenges, including the complexity of insulin production processes and the need to adhere to stringent regulatory standards for quality and safety. Additionally, addressing affordability concerns and potential supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on sustainable sourcing, research and development for efficient production methods, and addressing the challenges to meet the increasing demand for insulin while ensuring its accessibility to a diverse diabetic population worldwide.
This report aims to provide a comprehensive presentation of the global market for Insulin Raw Material, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Raw Material.
Report Scope
The Insulin Raw Material market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Raw Material market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Raw Material manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
Segment by Type
Regular Human Insulin
Insulin Analogue
Segment by Application
Fast-acting
Intermediate-acting
Long-acting
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Raw Material manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Raw Material in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Insulin Raw Material Market Overview
1.1 Product Overview and Scope of Insulin Raw Material
1.2 Insulin Raw Material Segment by Type
1.2.1 Global Insulin Raw Material Market Value Comparison by Type (2024-2030)
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Insulin Raw Material Segment by Application
1.3.1 Global Insulin Raw Material Market Value by Application: (2024-2030)
1.3.2 Fast-acting
1.3.3 Intermediate-acting
1.3.4 Long-acting
1.4 Global Insulin Raw Material Market Size Estimates and Forecasts
1.4.1 Global Insulin Raw Material Revenue 2019-2030
1.4.2 Global Insulin Raw Material Sales 2019-2030
1.4.3 Global Insulin Raw Material Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insulin Raw Material Market Competition by Manufacturers
2.1 Global Insulin Raw Material Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insulin Raw Material Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insulin Raw Material Average Price by Manufacturers (2019-2024)
2.4 Global Insulin Raw Material Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Raw Material, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Raw Material, Product Type & Application
2.7 Insulin Raw Material Market Competitive Situation and Trends
2.7.1 Insulin Raw Material Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Raw Material Players Market Share by Revenue
2.7.3 Global Insulin Raw Material Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Raw Material Retrospective Market Scenario by Region
3.1 Global Insulin Raw Material Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insulin Raw Material Global Insulin Raw Material Sales by Region: 2019-2030
3.2.1 Global Insulin Raw Material Sales by Region: 2019-2024
3.2.2 Global Insulin Raw Material Sales by Region: 2025-2030
3.3 Global Insulin Raw Material Global Insulin Raw Material Revenue by Region: 2019-2030
3.3.1 Global Insulin Raw Material Revenue by Region: 2019-2024
3.3.2 Global Insulin Raw Material Revenue by Region: 2025-2030
3.4 North America Insulin Raw Material Market Facts & Figures by Country
3.4.1 North America Insulin Raw Material Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insulin Raw Material Sales by Country (2019-2030)
3.4.3 North America Insulin Raw Material Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Raw Material Market Facts & Figures by Country
3.5.1 Europe Insulin Raw Material Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insulin Raw Material Sales by Country (2019-2030)
3.5.3 Europe Insulin Raw Material Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Raw Material Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Raw Material Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insulin Raw Material Sales by Country (2019-2030)
3.6.3 Asia Pacific Insulin Raw Material Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Raw Material Market Facts & Figures by Country
3.7.1 Latin America Insulin Raw Material Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insulin Raw Material Sales by Country (2019-2030)
3.7.3 Latin America Insulin Raw Material Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Raw Material Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Raw Material Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insulin Raw Material Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insulin Raw Material Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insulin Raw Material Sales by Type (2019-2030)
4.1.1 Global Insulin Raw Material Sales by Type (2019-2024)
4.1.2 Global Insulin Raw Material Sales by Type (2025-2030)
4.1.3 Global Insulin Raw Material Sales Market Share by Type (2019-2030)
4.2 Global Insulin Raw Material Revenue by Type (2019-2030)
4.2.1 Global Insulin Raw Material Revenue by Type (2019-2024)
4.2.2 Global Insulin Raw Material Revenue by Type (2025-2030)
4.2.3 Global Insulin Raw Material Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Raw Material Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insulin Raw Material Sales by Application (2019-2030)
5.1.1 Global Insulin Raw Material Sales by Application (2019-2024)
5.1.2 Global Insulin Raw Material Sales by Application (2025-2030)
5.1.3 Global Insulin Raw Material Sales Market Share by Application (2019-2030)
5.2 Global Insulin Raw Material Revenue by Application (2019-2030)
5.2.1 Global Insulin Raw Material Revenue by Application (2019-2024)
5.2.2 Global Insulin Raw Material Revenue by Application (2025-2030)
5.2.3 Global Insulin Raw Material Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Raw Material Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Insulin Raw Material Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi-Aventis
6.2.1 Sanofi-Aventis Corporation Information
6.2.2 Sanofi-Aventis Description and Business Overview
6.2.3 Sanofi-Aventis Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-Aventis Insulin Raw Material Product Portfolio
6.2.5 Sanofi-Aventis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly Insulin Raw Material Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Tonghua Dongbao
6.4.1 Tonghua Dongbao Corporation Information
6.4.2 Tonghua Dongbao Description and Business Overview
6.4.3 Tonghua Dongbao Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tonghua Dongbao Insulin Raw Material Product Portfolio
6.4.5 Tonghua Dongbao Recent Developments/Updates
6.5 Ganlee
6.5.1 Ganlee Corporation Information
6.5.2 Ganlee Description and Business Overview
6.5.3 Ganlee Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ganlee Insulin Raw Material Product Portfolio
6.5.5 Ganlee Recent Developments/Updates
6.6 United Laboratory
6.6.1 United Laboratory Corporation Information
6.6.2 United Laboratory Description and Business Overview
6.6.3 United Laboratory Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
6.6.4 United Laboratory Insulin Raw Material Product Portfolio
6.6.5 United Laboratory Recent Developments/Updates
6.7 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biocon Insulin Raw Material Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 Amphastar
6.8.1 Amphastar Corporation Information
6.8.2 Amphastar Description and Business Overview
6.8.3 Amphastar Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amphastar Insulin Raw Material Product Portfolio
6.8.5 Amphastar Recent Developments/Updates
6.9 Wockhardt
6.9.1 Wockhardt Corporation Information
6.9.2 Wockhardt Description and Business Overview
6.9.3 Wockhardt Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Wockhardt Insulin Raw Material Product Portfolio
6.9.5 Wockhardt Recent Developments/Updates
6.10 Julphar Diabetes
6.10.1 Julphar Diabetes Corporation Information
6.10.2 Julphar Diabetes Description and Business Overview
6.10.3 Julphar Diabetes Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Julphar Diabetes Insulin Raw Material Product Portfolio
6.10.5 Julphar Diabetes Recent Developments/Updates
6.11 Torrent Pharma
6.11.1 Torrent Pharma Corporation Information
6.11.2 Torrent Pharma Insulin Raw Material Description and Business Overview
6.11.3 Torrent Pharma Insulin Raw Material Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Torrent Pharma Insulin Raw Material Product Portfolio
6.11.5 Torrent Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Raw Material Industry Chain Analysis
7.2 Insulin Raw Material Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Raw Material Production Mode & Process
7.4 Insulin Raw Material Sales and Marketing
7.4.1 Insulin Raw Material Sales Channels
7.4.2 Insulin Raw Material Distributors
7.5 Insulin Raw Material Customers
8 Insulin Raw Material Market Dynamics
8.1 Insulin Raw Material Industry Trends
8.2 Insulin Raw Material Market Drivers
8.3 Insulin Raw Material Market Challenges
8.4 Insulin Raw Material Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Insulin Raw Material Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Insulin Raw Material Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Insulin Raw Material Market Competitive Situation by Manufacturers in 2023
Table 4. Global Insulin Raw Material Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Insulin Raw Material Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Insulin Raw Material Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Insulin Raw Material Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Insulin Raw Material Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Insulin Raw Material, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Insulin Raw Material, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin Raw Material, Product Type & Application
Table 12. Global Key Manufacturers of Insulin Raw Material, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Raw Material by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Raw Material as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Raw Material Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Insulin Raw Material Sales by Region (2019-2024) & (MT)
Table 18. Global Insulin Raw Material Sales Market Share by Region (2019-2024)
Table 19. Global Insulin Raw Material Sales by Region (2025-2030) & (MT)
Table 20. Global Insulin Raw Material Sales Market Share by Region (2025-2030)
Table 21. Global Insulin Raw Material Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Insulin Raw Material Revenue Market Share by Region (2019-2024)
Table 23. Global Insulin Raw Material Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Insulin Raw Material Revenue Market Share by Region (2025-2030)
Table 25. North America Insulin Raw Material Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Insulin Raw Material Sales by Country (2019-2024) & (MT)
Table 27. North America Insulin Raw Material Sales by Country (2025-2030) & (MT)
Table 28. North America Insulin Raw Material Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Insulin Raw Material Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Insulin Raw Material Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Insulin Raw Material Sales by Country (2019-2024) & (MT)
Table 32. Europe Insulin Raw Material Sales by Country (2025-2030) & (MT)
Table 33. Europe Insulin Raw Material Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Insulin Raw Material Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Insulin Raw Material Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Insulin Raw Material Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Insulin Raw Material Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Insulin Raw Material Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Insulin Raw Material Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Insulin Raw Material Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Insulin Raw Material Sales by Country (2019-2024) & (MT)
Table 42. Latin America Insulin Raw Material Sales by Country (2025-2030) & (MT)
Table 43. Latin America Insulin Raw Material Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Insulin Raw Material Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Insulin Raw Material Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Insulin Raw Material Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Insulin Raw Material Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Insulin Raw Material Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Insulin Raw Material Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Insulin Raw Material Sales (MT) by Type (2019-2024)
Table 51. Global Insulin Raw Material Sales (MT) by Type (2025-2030)
Table 52. Global Insulin Raw Material Sales Market Share by Type (2019-2024)
Table 53. Global Insulin Raw Material Sales Market Share by Type (2025-2030)
Table 54. Global Insulin Raw Material Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Insulin Raw Material Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Insulin Raw Material Revenue Market Share by Type (2019-2024)
Table 57. Global Insulin Raw Material Revenue Market Share by Type (2025-2030)
Table 58. Global Insulin Raw Material Price (US$/Kg) by Type (2019-2024)
Table 59. Global Insulin Raw Material Price (US$/Kg) by Type (2025-2030)
Table 60. Global Insulin Raw Material Sales (MT) by Application (2019-2024)
Table 61. Global Insulin Raw Material Sales (MT) by Application (2025-2030)
Table 62. Global Insulin Raw Material Sales Market Share by Application (2019-2024)
Table 63. Global Insulin Raw Material Sales Market Share by Application (2025-2030)
Table 64. Global Insulin Raw Material Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Insulin Raw Material Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Insulin Raw Material Revenue Market Share by Application (2019-2024)
Table 67. Global Insulin Raw Material Revenue Market Share by Application (2025-2030)
Table 68. Global Insulin Raw Material Price (US$/Kg) by Application (2019-2024)
Table 69. Global Insulin Raw Material Price (US$/Kg) by Application (2025-2030)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Novo Nordisk Insulin Raw Material Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi-Aventis Corporation Information
Table 76. Sanofi-Aventis Description and Business Overview
Table 77. Sanofi-Aventis Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Sanofi-Aventis Insulin Raw Material Product
Table 79. Sanofi-Aventis Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Eli Lilly Insulin Raw Material Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Tonghua Dongbao Corporation Information
Table 86. Tonghua Dongbao Description and Business Overview
Table 87. Tonghua Dongbao Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Tonghua Dongbao Insulin Raw Material Product
Table 89. Tonghua Dongbao Recent Developments/Updates
Table 90. Ganlee Corporation Information
Table 91. Ganlee Description and Business Overview
Table 92. Ganlee Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Ganlee Insulin Raw Material Product
Table 94. Ganlee Recent Developments/Updates
Table 95. United Laboratory Corporation Information
Table 96. United Laboratory Description and Business Overview
Table 97. United Laboratory Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. United Laboratory Insulin Raw Material Product
Table 99. United Laboratory Recent Developments/Updates
Table 100. Biocon Corporation Information
Table 101. Biocon Description and Business Overview
Table 102. Biocon Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Biocon Insulin Raw Material Product
Table 104. Biocon Recent Developments/Updates
Table 105. Amphastar Corporation Information
Table 106. Amphastar Description and Business Overview
Table 107. Amphastar Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Amphastar Insulin Raw Material Product
Table 109. Amphastar Recent Developments/Updates
Table 110. Wockhardt Corporation Information
Table 111. Wockhardt Description and Business Overview
Table 112. Wockhardt Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Wockhardt Insulin Raw Material Product
Table 114. Wockhardt Recent Developments/Updates
Table 115. Julphar Diabetes Corporation Information
Table 116. Julphar Diabetes Description and Business Overview
Table 117. Julphar Diabetes Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Julphar Diabetes Insulin Raw Material Product
Table 119. Julphar Diabetes Recent Developments/Updates
Table 120. Torrent Pharma Corporation Information
Table 121. Torrent Pharma Description and Business Overview
Table 122. Torrent Pharma Insulin Raw Material Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Torrent Pharma Insulin Raw Material Product
Table 124. Torrent Pharma Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Insulin Raw Material Distributors List
Table 128. Insulin Raw Material Customers List
Table 129. Insulin Raw Material Market Trends
Table 130. Insulin Raw Material Market Drivers
Table 131. Insulin Raw Material Market Challenges
Table 132. Insulin Raw Material Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insulin Raw Material
Figure 2. Global Insulin Raw Material Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Insulin Raw Material Market Share by Type in 2023 & 2030
Figure 4. Regular Human Insulin Product Picture
Figure 5. Insulin Analogue Product Picture
Figure 6. Global Insulin Raw Material Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Insulin Raw Material Market Share by Application in 2023 & 2030
Figure 8. Fast-acting
Figure 9. Intermediate-acting
Figure 10. Long-acting
Figure 11. Global Insulin Raw Material Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Insulin Raw Material Market Size (2019-2030) & (US$ Million)
Figure 13. Global Insulin Raw Material Sales (2019-2030) & (MT)
Figure 14. Global Insulin Raw Material Average Price (US$/Kg) & (2019-2030)
Figure 15. Insulin Raw Material Report Years Considered
Figure 16. Insulin Raw Material Sales Share by Manufacturers in 2023
Figure 17. Global Insulin Raw Material Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Insulin Raw Material Players: Market Share by Revenue in 2023
Figure 19. Insulin Raw Material Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Insulin Raw Material Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Insulin Raw Material Sales Market Share by Country (2019-2030)
Figure 22. North America Insulin Raw Material Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Insulin Raw Material Sales Market Share by Country (2019-2030)
Figure 26. Europe Insulin Raw Material Revenue Market Share by Country (2019-2030)
Figure 27. Germany Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Insulin Raw Material Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Insulin Raw Material Revenue Market Share by Region (2019-2030)
Figure 34. China Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Insulin Raw Material Sales Market Share by Country (2019-2030)
Figure 45. Latin America Insulin Raw Material Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Insulin Raw Material Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Insulin Raw Material Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Insulin Raw Material Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Insulin Raw Material by Type (2019-2030)
Figure 55. Global Revenue Market Share of Insulin Raw Material by Type (2019-2030)
Figure 56. Global Insulin Raw Material Price (US$/Kg) by Type (2019-2030)
Figure 57. Global Sales Market Share of Insulin Raw Material by Application (2019-2030)
Figure 58. Global Revenue Market Share of Insulin Raw Material by Application (2019-2030)
Figure 59. Global Insulin Raw Material Price (US$/Kg) by Application (2019-2030)
Figure 60. Insulin Raw Material Value Chain
Figure 61. Insulin Raw Material Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
